Chronic Bronchitis Clinical Trials
2 recruiting trials for Chronic Bronchitis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Chronic Bronchitis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Suzhou Hengruihongyuan Medical Technology Co. LTD (1), COPD Foundation (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Pulse electric field ablation system (device, 1 trial), followed by Sham Procedure, Patient Reported Outcomes.
Track Chronic Bronchitis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
This is a prospective, randomized, parallel group, sham-controlled, multicenter clinical trial. The objective is to evaluate the safety and effectiveness of pulsed electric field...
COPD Patient-Powered Research Network
The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Chronic Bronchitis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Chronic Bronchitis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Chronic Bronchitis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.